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Abstract. In clinics, blood coagulation time measurements are performed using mechanical measurements with
blood plasma. Such measurements are challenging to do in a lab-on-a-chip (LoC) system using a small volume
of whole blood. Existing LoC systems use indirect measurement principles employing optical or electrochemical
methods. We developed an LoC system using mechanical measurements with a small volume of whole blood
without requiring sample preparation. The measurement is performed in a microfluidic channel where two fibers
are placed inline with a small gap in between. The first fiber operates near its mechanical resonance using
remote magnetic actuation and immersed in the sample. The second fiber is a pick-up fiber acting as an optical
sensor. The microfluidic channel is engineered innovatively such that the blood does not block the gap between
the vibrating fiber and the pick-up fiber, resulting in high signal-to-noise ratio optical output. The control plasma
test results matched well with the plasma manufacturer’s datasheet. Activated-partial-thromboplastin-time tests
were successfully performed also with human whole blood samples, and the method is proven to be effective.
Simplicity of the cartridge design and cost of readily available materials enable a low-cost point-of-care device for
blood coagulation measurements. © The Authors. Published by SPIE under a Creative Commons Attribution 3.0 Unported License.
Distribution or reproduction of this work in whole or in part requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1.
JBO.22.11.117001]
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1 Introduction
Blood coagulation tests are required for most surgical opera-
tions,1 hepatic and renal disorders,2 and dengue hemorrhagic
fever conditions.3 Furthermore, patients receiving anticoagulant
treatments4 and patients with a risk of cardiac problems such as
embolism, atrial fibrillation, or stroke need to undergo blood
coagulation tests periodically since the dosage of anticoagulants
must be adjusted according to blood coagulation test results.5
Over 800 million coagulation tests are performed each year,
mostly in hospitals and clinical laboratories for emergency sit-
uations and surgical operations, as well as periodic monitoring
of certain patients.6 There are two golden standard techniques
extensively used in clinical coagulation monitoring: optical and
direct mechanical.7 All clinical measurements of coagulation
monitoring are conducted on plasma samples extracted from
whole blood by centrifuging.
Portable point-of-care (PoC) coagulation monitoring devices
have also been developed for emergency situations and for
patient self-testing.7,8 Such coagulation devices need to operate
with a small volume (10 to 20 μL finger prick sample) and with-
out plasma extraction.7,9 Existing PoC coagulation measurement
devices primarily use optical or electrochemical measurement
principles, which are indirect methods and have limitations.8
Electrochemical detection method is the dominant method
used in commercial PoC coagulation measurement devices
e.g., CoaguChek XS (Roche Diagnostics)7 and i-STAT
(Abbott Diagnostics).5 As blood coagulates, electrical resistance
of the blood changes and gives an indication of coagulation
time.10 These devices can operate with small sample volumes
using cartridges or strips.11 However, they have two major dis-
advantages related to reliability of the results: (i) chemical and
biological coatings applied in the cartridges need to be consis-
tent for all cartridges since an induced electrical current strongly
depends on the ionic composition of the blood,7 (ii) results are
susceptible to multiple drug interactions and certain health
conditions.12,13 Although the coating consistency problem can
be solved with a well-controlled strip fabrication process and
strip calibration, the second problem cannot be addressed easily.
In optical transmission-based methods, the signal-to-noise
ratio (SNR) of the monitored signal is low due to the complex
nature of whole blood.14,15 On the other hand, microfluidic
constriction-based optical detection methods utilize flow rate
change of blood in a microfluidic channel by clot formation.7
The readout is usually performed with simple optical sensors.
However, microfluidic cessation-based devices are very sensi-
tive to minute viscosity variations among individual users
and thus require calibration, which is not a straightforward proc-
ess for every patient.16,17 Another technique is measurement of
clot formation by inspecting fibrins visually: a wheel-like struc-
ture tries to catch fibrins formed during coagulation and a photo-
detector detects fibrins.18 However, the size of the device and the*Address all correspondence to: Hakan Urey, E-mail: hurey@ku.edu.tr
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complex blood insertion mechanism degrade the suitability
of this system as a PoC device. Previously, dynamic light
scattering-based methods are also proposed.19,20 However, these
systems have very complex measurement platforms (blood
circulation path and detector array arrangements), which are
not compatible with PoC applications.
An MEMS-based coagulation measurement platform, which
is able to perform direct mechanical measurement by employing
a resonating MEMS cantilever, has been developed for viscosity
and plasma coagulation measurements by our group.21–25
Although results with plasma were very promising, optome-
chanical tolerances were tight and whole blood results were
not reliable due to scattering and low optical transmission.
In this study, we developed a portable lab-on-a-chip (LoC)
system for direct measurement of coagulation time using whole
blood. The system consists of a reader unit that houses the
electronics, light source, and photodetectors and a disposable
cartridge inserted in the reader unit. Our method closely mimics
the golden standard used in clinics and overcomes the chal-
lenges associated with small sample volumes, strict optome-
chanical alignment requirements, and whole blood operation.
Our method is a direct mechanical method as it uses a vibrating
optical fiber operated in the blood sample. Low SNR problems
were addressed using an engineered microfluidic channel,
which separates blood interaction and measurement regions
of the vibrating fiber.
2 Materials and Methods
2.1 Cartridge and Reader Unit
The schematic top view of the measurement setup is shown in
Fig. 1(a). The cartridge is a single-use disposable piece with flu-
idic inlet and outlets for whole blood. The measurement is per-
formed in a microfluidic channel where a vibrating fiber and
a pick-up fiber are placed inline with a small gap in between.
The vibrating fiber operates near its mechanical resonance using
magnetic actuation and immersed in the whole blood sample.
The magnetic actuation is achieved by a small nickel piece
attached to the free-end of the vibrating fiber. The pick-up
fiber is immobilized in the channel and collects the optical signal
from the vibrating fiber. A key feature of the system is that the
microfluidic channel has a fluid stop region, which prevents the
blood from getting into the gap between the vibrating fiber and
the pick-up fiber. Having a clear optical path in the fluid stop
region avoids scattering and optical losses, which results in high
SNR optical output. Furthermore, no electrical connection to the
cartridge is needed since both the actuation and the readout are
done remotely.
The electronics, optical components, and electrocoil sur-
rounding the disposable cartridge are part of the reader unit.
The system uses an electromagnetic actuator to drive a vibrating
optical fiber inside the cartridge and an optical sensor. The dis-
posable cartridge is placed on top of an electromagnetic coil
embedded inside an aluminum fixture. The optical readout
employs a light-emitting diode (LED) and a photodetector,
which are pigtailed to multimode fibers in the reader unit.
These multimode fibers are butt coupled to two respective fibers
that are placed in the cartridge as detailed in the next section.
The optical signal generated in the cartridge is processed by
the postdetection electronics.
Control electronics consist of a signal generator, a current
amplifier to drive the electromagnetic coil, and a lock-in ampli-
fier (Zurich Instruments HF2LI) to detect the amplitude and the
relative phase of the photodetector signal. The signal generator
operates at a constant frequency near the mechanical resonance
of the vibrating optical fiber.
A photo of the measurement setup with cartridge is shown in
Fig. 1(b).
Precise temperature control is very important because coagu-
lation time heavily depends on temperature.26 A custom temper-
ature control unit was designed for reliable and repeatable
testing. The temperature control unit consists of heating wire
buried inside the aluminum fixture, a temperature sensor
(Analog Devices AD590), and a custom design controller cir-
cuit. Moreover, the aluminum fixture, cartridges, and fluid sam-
ples were preheated to 37°C. Temperature stability of 0.05°C
at 37°C was achieved with the described setup.
Fig. 1 (a) Schematic of the measurement setup. Optical fiber is actuated remotely by an electrocoil.
Optical signal is collected through a silicon photodetector. Amplitude and phase of the signal are moni-
tored by a lock-in amplifier. (b) A photo of the measurement setup with cartridge. Blood sample is inserted
into the microfluidic channel through an inlet. Blood flows with capillary motion into the cartridge.
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2.2 Measurement Principle
When blood or plasma coagulates, a sudden change in viscoe-
lasticity occurs by clot formation.27 There are two elements of
viscoelasticity: viscosity and elasticity. The viscosity of the
liquid affects the resonant frequency and quality factor of the
vibrating fiber. As the viscosity of the liquid medium changes,
resonant characteristics of the fiber change due to hydrodynamic
loading, as detailed in Sader’s study.28,29 When blood coagu-
lates, the viscosity increases and causes a decrease in the reso-
nant frequency and quality factor of the cantilever. Furthermore,
elasticity of the blood increases by fibrin formation; hence, the
spring constant of the fiber cantilever increases,30 which reduces
the vibration amplitude and increases the resonance frequency.
The implemented optical readout principle is based on modulat-
ing the optical power coupled from the vibrating fiber to the
pick-up fiber. There is a net change in system dynamics, which
produces a clear optical signal when the amplitude and the phase
of the optical detector are monitored.
2.3 Cartridge Fabrication
The cartridge has two parts: body and optical fibers. We used
multimode optical fibers in the cartridge with a core diameter
of 400 μm and cladding diameter of 440 μm. For both the res-
onating and pick-up fibers, jackets were stripped and cut to the
designed length with a fiber optic cleaver. For a better light cou-
pling, both ends of the fibers were polished using a fiber polish-
ing kit and were cleaned with isopropyl alcohol and distilled
water. A high purity nickel wire piece with a length of 1 mm
and a diameter of 350 μm was glued onto the resonating fiber
part using a low viscosity super glue (Pattex Sekundenkleber
Plastix Flüssig, Germany). The glued nickel part makes mag-
netic actuation possible for the resonating fiber.
The body of the cartridge consists of two polymethyl meth-
acrylate (PMMA) parts. Microfluidics and grooves are CNC
machined into PMMA sheets with a high accuracy micromilling
machine (MDA Presicion). Grooves are designed to hold the
fibers tightly. Precise machining of these grooves is important
because of the alignment of the fibers with respect to each other.
The machining process was calibrated vigorously on a regular
basis; test samples were measured with a white light interferom-
eter. An accuracy of 5 μm was achieved in microfluidic
channels. There are one inlet, one outlet, a sensor chamber,
and a fluid stop region as microfluidics. The microfluidic chan-
nel and inlet geometries are specifically designed to provide
fluid flow without pumping or surface functionalization. Thus,
eliminating extra cost and complexity of pumping and surface
functionalization enables a more robust and low cost cartridge.
Employing optical readout in blood is challenging because of
the high absorbent and scattering characteristics of red blood
cells.31 Thus, we developed a technique that enables optical
readout using a fluid stop region. The fluid stop region is located
where two ends of the fiber parts meet each other. This region
prevents fluid from going in between the two fiber ends via
capillary action. Capillary action is the tendency of fluid to
flow into smaller gaps rather than larger gaps. The fluid stop
region is machined much larger in terms of both height and
width with respect to the sensor chamber to decrease the capil-
lary force inside this region. The adhesion of the liquid to chan-
nel walls and cohesion of the liquid around air–fluid interface
prevent fluid from going into the fluid stop region, where the
two fibers face each other. Furthermore, trapped air in the
fluid stop aids prevention of leakage of blood into the fluid
stop region. Figure 2(a) shows the fluid stop region, sensor
chamber, fibers and blood flow with LED source, photodetector,
and coil. In our cartridges, the sensor chamber is machined to
800-μm depth and 1-mm width whereas the fluid stop region is
machined to 1.6-mm height and 2-mm width. Since blood flow
inside the cartridge is also promoted by capillary motion, a pos-
sible forced flow into the fluid stop region is prevented as shown
in Fig. 2(b). Preventing light from going through blood by
employing a fluid stop region enables a robust optical readout
scheme with high SNR. Note that the Ni piece is not attached to
the fiber cantilever shown in Fig. 2(a), since it is not a functional
cartridge but fabricated only for liquid stop region optimization.
The assembly procedure of the cartridge can be explained as
follows. Fiber parts are placed into grooves on the bottom car-
tridge body and prefixed with 1% aqueous polyvinyl alcohol
solution and dried in vacuum chamber for 20 min. Then, two
body parts of the cartridge are tightly put together with clamps.
UV-cured epoxy (Norland Products Optical Adhesive 81) is
wicked between two body parts and cured with UV light.
Since wicking epoxy automatically stops at the edges of micro-
fluidic channels due to capillary action, this bonding method
Fig. 2 (a) A cross sectional 3-D sketch of the cartridge with electrocoil. Blood inlet and outlet are not
shown. Blood does not get into the fluid stop region due to capillary force at the boundary. (b) Top view
microscope picture of the fluid stop region with blood in the microfluidic channel. Note that the tip of the
fiber is free to move; there is no physical barrier. Also note that the Ni piece is not attached to the fiber
cantilever shown here since it is not a functional cartridge but fabricated only for fluid stop illustration.
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enables easy all around sealing for complex channel geometries.
Note that clean room processes are not needed for the sensor
fabrication, which reduces cost and time significantly.
3 Results and Discussion
3.1 Sensor Characterization
The system was first characterized with various samples.
Frequency sweeps were conducted with the same cartridge
in air, distilled water, uncoagulated plasma, and coagulated
plasma. Figures 3(a) and 3(b) show the frequency response
of the system for different fluids. The resonant frequency of
the sensor in air is 4703 Hz, and the quality factor is 62.
When distilled water is inserted into the microfluidic channel,
the resonance frequency drops to 4300 Hz and the quality factor
drops to 34 due to hydrodynamic effects. Frequency sweeps
were performed before and 3 min after coagulation with control
plasmas. Similar to the air and distilled water tests, both the res-
onance frequency and the quality factor decreased. In uncoagu-
lated plasma, the resonance frequency was 4214 Hz, and the
quality factor was 29; after coagulation, the resonance frequency
and the quality factor dropped to 4191 Hz and 22, respectively.
The change in resonance frequency is not very large, but the
changes in amplitude and phase response of the system are sig-
nificant. As can be seen in Fig. 3(b), the amounts of change for
amplitude and phase are different for particular frequencies.
For instance, a decrease in amplitude is maximum at around
4200 Hz whereas a change in phase is maximum at around
4120 and 4350 Hz. Moreover, the phase can decrease or increase
depending on the drive frequency whereas amplitude only
decreases due to increased viscous drag and elasticity. Since
the proposed system is more sensitive for amplitude, measure-
ments were conducted at a fixed frequency around the resonant
frequency of the vibrating fiber. The described characterization
procedure was applied to all cartridges to minimize the effect
of differences between individual cartridges and samples to
achieve accurate and repeatable results with high SNR.
Blood coagulation times are usually measured with either PT
or activated partial thromboplastin time (aPTT) test protocols.32
The average PT test time is around 13 s while the average aPTT
test time is much longer at around 30 s.33 Even with a severe
abnormality, aPTT tests do not exceed 90 s.34 Figures 3(c)
and 3(d) show long-term amplitude and phase stability of the
system in distilled water for 10 min, which is more than six
times longer than aPTT times of severely abnormal blood sam-
ples. The stability measurement yielded a standard deviation of
1.2 mVand a standard deviation of 0.35 deg in phase difference
between the drive and readout signals. SNR of the amplitude is
calculated as 125 by taking the standard deviation of 1.2 mV as
the noise floor of the system and signal as 150 mV, which is the
average amplitude change due to coagulation. Similarly, SNR of
the phase is calculated as 18.5 by taking the standard deviation
of 0.35 deg as the noise floor of the system and signal as 6.5 deg,
which is the average phase change due to coagulation.
3.2 aPTT Measurements with Control Plasma
In the scope of this report, aPTT tests were conducted using the
proposed system using control plasma and whole blood sam-
ples. We used three different control plasma samples: normal
(DIAGEN, UK, lot No.: KP93), abnormal 1 (DIAGEN, UK,
lot No.: AB1-80), and abnormal 2 (DIAGEN, UK, lot No.:
AB2-79). While normal control plasma samples have coagula-
tion times similar to a healthy person’s, the abnormal 1 sample
has mild abnormality in coagulation time and the abnormal 2 has
severe abnormality. Before measurements, all control samples
and reagents were warmed to 37°C in a water bath, and the alu-
minum fixture was preheated to 37°C by the temperature control
Fig. 3 Frequency response of the system to air, distilled water, uncoagulated blood plasma, and blood
plasma after coagulation. Amplitude and phase change are shown in (a) and (b), respectively.
(c) Amplitude and (d) phase stability of the sensor in distilled water for 10 min. Amplitude has a standard
deviation of 1.2 mV, and phase has a standard deviation of 0.35 deg.
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unit. For aPTT tests, 50 μL of control plasma was mixed with
50-μL micronized silica/platelet substitute mixture (DIAGEN,
UK, lot No.: SP66), which is a common aPTT reagent, used
in coagulation tests. The control plasma–reagent mixture was
incubated for exactly 5 min. After incubation, 50 μL of the
25-mM CaCl2 solution was mixed with the control plasma–
reagent mixture, and 12 μL of this final mixture was inserted
into the cartridge immediately. Since control plasma samples
are citrated, the coagulation process does not start until the intro-
duction of CaCl2. Therefore, mixing the CaCl2 solution into
the mixture is taken as t ¼ 0. While coagulation was observed
through amplitude, the remaining sample was pipetted regularly
and observed for clot formation to have an external confirmation
for coagulation.
The amplitude and phase response of the system for aPTT
test from control plasma can be seen in Fig. 4(a). A sudden
decrease in both amplitude and phase is observed around
48 s due to clotting. The drive signal frequency was chosen
to maximize the change in the signal amplitude. Therefore,
the phase change is less noticeable. The circular cross section
shape of the optical fiber has significantly less drag coefficient
compared with the flat surface of conventional cantilevers
that are used in biosensor applications. A more aerodynamic
structure shape results in less drag force applied by the viscous
medium. Therefore, a change in the movement of the optical
fiber is less sensitive to viscosity change. However, the optical
readout scheme presented in this report is very sensitive to
mechanical displacement, which results in a high electrical read-
out amplitude. On the other hand, the sensitivity of phase change
is lower than the sensitivity of amplitude change since it is inher-
ently related to the cantilever structure regardless of the readout
scheme. Since alignment of the cartridge to the reader unit is less
sensitive compared with MEMS-based sensors,22,23 the ampli-
tude readout does not suffer from coupling variations among
different cartridges. Therefore, we decided to monitor coagula-
tion through amplitude change.
The signal amplitude is observed for more than 1 min in the
system. A polynomial was fitted to amplitude data, and the first
derivative of this polynomial was calculated. In Fig. 4(b), raw
amplitude data, polynomial fitted data, and first derivative of the
polynomial fit are shown. There are two important points in
the derivative data. First, the derivative that is zero can be inter-
preted as the start of coagulation. Second, the local minima of
the derivative can be interpreted as the midpoint of the
coagulation. Since the local minima well overlaps with both
plasma manufacturer data sheet and control samples that
were observed outside the channel by pipetting to test the coagu-
lation, the local minima time of the first derivate was used for
quantitative coagulation times. Figure 5 shows measurement
results and their derivative for normal, abnormal 1, abnormal
2 control plasma, and whole blood samples. The measurement
of each control plasma sample was repeated three times for dif-
ferent plasma samples to check the reproducibility. Cartridge to
cartridge variation caused by the fabrication process and varia-
tion among control plasma samples may affect the overall sys-
tem response. Therefore, it is important to have reproducible
data with different cartridges and samples to assure a reliable
diagnostic assay.
Figure 5(a) shows normalized aPTT test results obtained
from different control plasma samples. Since every coagulom-
eter platform has a different sensing mechanism and different
test protocols, there is a high chance of obtaining different
results from the same sample. To prevent variations among
different platforms, normalized aPTT values are used.35
Normalized aPTT is calculated by dividing the test result by
the average aPTT time for the specific setup and protocol.
First derivatives of the normalized amplitudes are used for
time calculations as explained earlier [Fig. 5(b)]. The average
of results obtained from normal control plasma samples were
equated to mean a normalized aPTT value of 1.03, which is
given in the plasma manufacturer datasheet. For abnormal 1
and abnormal 2 normalized aPTT values, 1.03 was used as refer-
ence. Unlike the phase readout, the amplitude level may change
cartridge to cartridge due to light coupling condition variances
and the fabrication process. Therefore, in addition to aPTT time
normalization, amplitude levels were also normalized to unity
by dividing maximum amplitude for convenient data represen-
tation. The normalized aPTT ratio, standard deviation (σ), and
relative standard deviation (RSD) for control plasma samples are
shown in Table 1. Test results match well with data provided by
the manufacturer datasheet. There is 1.36% RSD for abnormal 1
and 0.9% for abnormal tests.
3.3 aPTT Measurements with Whole Blood
While clinics perform coagulation measurement using large vol-
umes of blood and separate the plasma, PoC devices perform
measurements from low volumes without plasma separation.
Fig. 4 (a) Amplitude and phase change during coagulation of abnormal 1 control plasma. (b) Polynomial
fit to amplitude and its first derivative. Time of local minimum of the derivative is reported as coagulation
times. First zero crossing of the derivative indicates the clot formation time.
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Our system was tested with whole blood samples collected from
a 24-year-old male healthy donor. The donation of human whole
blood samples from healthy donors for this study was approved
by the Koç University Ethical Committee, and healthy volun-
teers signed an informed consent. Blood samples were stored
in 1.8-mL citrated blood vials (Greiner Bio One Vacuette
454326 polyethylene terephthalate sodium citrate blood collec-
tion coagulation tube, 3.2% sodium citrate). Before measure-
ments, all blood samples, reagents, and the system were
warmed to 37°C. For aPTT tests, 50 μL of whole blood was
mixed with 50-μL micronized silica/platelet substitute mixture
(DIAGEN, UK, lot No.: SP66). Citrated vials bind the Caþ ions
present in the whole blood samples. It is important to add Caþ
ions since Caþ ions aid the fibrin formation. The whole blood–
reagent mixture was incubated for exactly 5 min. After incuba-
tion, 50 μL of 25-mM CaCl2 solution was mixed with the whole
blood–reagent mixture, and 12 μL of this final mixture was
inserted into the cartridge immediately. Since whole blood sam-
ples are citrated, the coagulation process does not start until the
introduction of CaCl2. Therefore, mixing of CaCl2 solution into
the mixture is taken as t ¼ 0. While coagulation was observed
through amplitude, the remaining sample was pipetted regularly
and observed for clot forming to have an external confirmation
for coagulation.
Figure 5(c) shows aPTT measurements of the blood samples
taken from the same donor. Similar to control plasma tests,
a sharp decrease in amplitude is observed when coagulation
occurs. For three different tests, coagulation times were calcu-
lated at 36, 36.5, and 37.5 s using first derivatives [Fig. 5(d)].
Since there is no control whole blood sample readily available
for coagulometer calibration, control plasma measurements
were used for calibration purposes. Test results of whole
blood samples yielded 0.76 s standard deviation and 2% RSD,
encouraging a PoC coagulameter application for the proposed
system.
4 Conclusions
In this study, a direct mechanical coagulation measurement
platform enabling measurements from whole blood samples
was demonstrated. The system consists of a reader unit and a
disposable cartridge with a simple fabrication process. Dispos-
able cartridges have fiber optic-based sensors and microfluidic
channels. The readout was performed optically, which is
enabled by the microfluidic design. Since the optical readout
is performed by a single photodetector, the cartridge and optical
interface of the reader unit are simple compared with other opti-
cal readout architectures where laser Doppler vibrometer22 or
diffractive optics23 were used.
Fig. 5 (a) aPTT tests with normal, abnormal 1, and abnormal 2 control plasmas. Each test was repeated
three times with the same control plasma samples but different cartridges. (b) First derivatives of control
plasma results show the local minima. (c) aPTT tests were repeated for human whole blood sample three
times with the same sample but different cartridges. (d) First derivatives of whole blood results show
the local minima. σ ¼ 0.76 s and RSD% ¼ 2.
Table 1 Normalized aPTT test results of control plasmas versus




aPTT ratio σ RSD%
Normalized
aPTT ratio σ RSD%
Normal 1.03 0.014 1.36 1.03 0.007 0.68
Abnormal 1 1.45 0.007 0.48 1.4 0.015 1.05
Abnormal 2 2.22 0.012 0.54 2.2 0.038 1.73
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The fluid stop region is an important invention in our design.
It was added to the microfluidic channel to prevent fluids from
interfering with the optical readout and enabled high SNR opti-
cal signals.
aPTT tests were performed successfully with various control
plasmas and with whole blood samples with RSD% less than
2% in all cases. Repeatability of the results and the precision
in coagulation time measurement were very good. Results
reported in this study were obtained from a bench top prototype;
a handheld reader unit prototype is currently under develop-
ment. Initial results and simplicity of the cartridge design prom-
ise a low-cost PoC device for blood coagulation measurement.
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